Experimental Rodent Models of Cardiovascular Diseases

Tian Jia,Chen Wang,Zhengxi Han,Xiaozhi Wang,Ming Ding,Quanyi Wang
DOI: https://doi.org/10.3389/fcvm.2020.588075
IF: 3.6
2020-12-07
Frontiers in Cardiovascular Medicine
Abstract:Cardiovascular diseases, as the most common non-communicable disease in the world, cause a high mortality rate today and bring a serious medical burden to countries worldwide, especially in low- and middle-income countries. Experimental rodent models are widely used for cardiovascular diseases researches due to the effective simulation of human cardiovascular diseases, strong reproductive ability, and easy detection. Herein, we will summarize the pathological manifestations of common cardiovascular diseases and illustrate the establishment of corresponding experimental rodent models in detail.
cardiac & cardiovascular systems
What problem does this paper attempt to address?
The paper primarily discusses the methods for establishing experimental rodent models of cardiovascular diseases and their applications in research. Specifically, the paper attempts to address the following aspects: 1. **Pathological Manifestations of Cardiovascular Diseases**: The paper first outlines the pathological manifestations of common cardiovascular diseases, including coronary atherosclerotic heart disease, hypertensive heart disease, heart failure, rheumatic heart disease, pulmonary heart disease, myocarditis, and congenital heart disease. 2. **Establishment of Rodent Models**: The paper provides a detailed introduction to the methods for establishing rodent models to simulate these cardiovascular diseases. For example: - **Coronary Atherosclerotic Heart Disease**: Models are established using APOE gene knockout mice (Apoe−/−) or low-density lipoprotein receptor gene knockout mice (LDLR−/−). - **Hypertensive Heart Disease**: Models are established using spontaneously hypertensive rats (SHRs) or by injecting angiotensin II or aldosterone. - **Heart Failure**: Models are established by ligating the left anterior descending coronary artery or performing transverse aortic constriction surgery (TAC). - **Rheumatic Heart Disease**: Models are established by inducing autoimmune valvulitis through the injection of streptococcal M5 protein. - **Congenital Heart Disease**: Models are established by introducing Nkx2-5 gene mutations or GATA4 gene mutations. 3. **Advantages and Limitations of Different Models**: The paper also analyzes the advantages and limitations of various models to provide references for cardiovascular disease research. For example, genetic models have uniform phenotypes and good controllability but require long breeding times and are costly; special diet models are simple to operate and have low food costs but exhibit significant individual differences and longer experimental cycles. In summary, this paper aims to provide a series of reliable rodent models for cardiovascular disease research and to offer guidance for future research work.